SHAREHOLDER ALERT: Investigation of Nabriva Announced by Holzer & Holzer, LLC
ATLANTA--(BUSINESS WIRE)--May 1, 2019--Holzer & Holzer, LLC is investigating whether certain statements made by Nabriva Therapeutics plc (“Nabriva” or the “Company”)(NASDAQ: NBRV) complied with federal securities laws. On April 30, 2019, Nabriva issued a press release announcing that it received a Complete Response Letter from the FDA requesting that the Company address issues related to facility inspections and manufacturing deficiencies at one of its contract manufacturers. Nabriva’s stock price fell following the announcement.
If you purchased Nabriva shares and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at firstname.lastname@example.org or Marshall P. Dees, Esq. at email@example.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190501005780/en/
CONTACT: Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
KEYWORD: UNITED STATES NORTH AMERICA GEORGIA
INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL
SOURCE: Holzer & Holzer, LLC
Copyright Business Wire 2019.
PUB: 05/01/2019 12:11 PM/DISC: 05/01/2019 12:11 PM